Vasculoprotector

Details Vasculoprotector Vasculoprotector

A - Human Necessities

61

K

A61K 31/35 (2006.01) A61K 31/352 (2006.01) C12N 5/06 (2006.01)

Patent

CA 2331885

The invention relates to a method of inducing a vasculoprotective effect, particularly relating to restonosis, angioplasty, chronic allograft rejection, diabetic angiopathy, autoimmune angiopathy, ateriosclerosis and atherosclerosis in a subject, the method comprising treating the subject with an ERbeta agonist. The preferred Estrogen Receptor beta agonist is genistein.

L'invention concerne une méthode permettant d'induire un effet vasculoprotecteur chez un sujet. Cette méthode consiste à traiter le sujet à l'aide d'un agoniste ER.beta..

Affiliated with

Also associated with

Rating

Vasculoprotector does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vasculoprotector, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vasculoprotector will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1515105